UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$646M |
| 2 |
Automatic Data Processing
ADP
|
+$510M |
| 3 |
Baidu
BIDU
|
+$349M |
| 4 |
Tesla
TSLA
|
+$320M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$758M |
| 2 |
Shopify
SHOP
|
+$568M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$521M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Healthcare | 13.27% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Communication Services | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Corcept Therapeutics
CORT
$12.3B
| $3.79M | ﹤0.01% |
168,213
+18,615
| +12% | +$396K |
|
1427
Leslie's
LESL
$10.4M
| $3.79M | ﹤0.01% |
9,783
+2,576
| +36% | +$1.07M |
|
|
HCP
1428
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $3.77M | ﹤0.01% |
69,900
-4,600
| -6% | -$268K |
|
1429
Gentherm
THRM
$1.27B
| $3.77M | ﹤0.01% |
51,619
+4,348
| +9% | +$362K |
|
1430
BioCryst Pharmaceuticals
BCRX
$2.51B
| $3.76M | ﹤0.01% |
231,150
+26,827
| +13% | +$430K |
|
1431
CarGurus
CARG
$3.35B
| $3.73M | ﹤0.01% |
87,824
-4,843
| -5% | -$178K |
|
1432
First Interstate BancSystem
FIBK
$3.56B
| $3.72M | ﹤0.01% |
101,281
+55,979
| +124% | +$2.21M |
|
1433
CVB Financial
CVBF
$3.97B
| $3.72M | ﹤0.01% |
160,425
-1,365
| -0.8% | -$31.6K |
|
1434
MACOM Technology Solutions
MTSI
$22.7B
| $3.72M | ﹤0.01% |
62,145
-8,070
| -11% | -$504K |
|
|
ACH
1435
Accendra Health
ACH
$107M
| $3.71M | ﹤0.01% |
84,204
-17,711
| -17% | -$760K |
|
1436
Resideo Technologies
REZI
$3.67B
| $3.69M | ﹤0.01% |
154,984
-1,360
| -0.9% | -$34.1K |
|
|
NUVA
1437
DELISTED
NuVasive, Inc.
NUVA
| $3.68M | ﹤0.01% |
64,877
+8,055
| +14% | +$428K |
|
1438
First Financial Bancorp
FFBC
$3.53B
| $3.68M | ﹤0.01% |
159,484
+16,485
| +12% | +$410K |
|
1439
Allogene Therapeutics
ALLO
$725M
| $3.67M | ﹤0.01% |
402,857
+12,895
| +3% | +$134K |
|
|
RTL
1440
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $3.67M | ﹤0.01% |
463,367
+30,637
| +7% | +$248K |
|
|
LAZR
1441
DELISTED
Luminar Technologies
LAZR
| $3.66M | ﹤0.01% |
15,618
+3,512
| +29% | +$770K |
|
1442
American Eagle Outfitters
AEO
$3.07B
| $3.66M | ﹤0.01% |
217,833
+5,546
| +3% | +$117K |
|
|
ALTR
1443
DELISTED
Altair Engineering Inc
ALTR
| $3.66M | ﹤0.01% |
56,809
+5,550
| +11% | +$350K |
|
1444
RLX Technology
RLX
$2.44B
| $3.64M | ﹤0.01% |
2,030,770
-19,000
| -0.9% | -$56.5K |
|
|
MDRX
1445
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.62M | ﹤0.01% |
160,929
-22,294
| -12% | -$452K |
|
1446
Iovance Biotherapeutics
IOVA
$2.9B
| $3.62M | ﹤0.01% |
217,535
+39,474
| +22% | +$610K |
|
1447
Dana Inc
DAN
$3.21B
| $3.62M | ﹤0.01% |
206,107
+5,421
| +3% | +$111K |
|
1448
KB Home
KBH
$3.47B
| $3.6M | ﹤0.01% |
111,185
+5,148
| +5% | +$203K |
|
1449
Progyny
PGNY
$2.18B
| $3.6M | ﹤0.01% |
70,039
+7,995
| +13% | +$342K |
|
1450
Thomson Reuters
TRI
$45.2B
| $3.59M | ﹤0.01% |
31,320
-1,089,523
| -97% | -$122M |
|
Similar funds
UBS AM's Q1 2022 Portfolio in Review
As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Baidu worth $306M.
- UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
- UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
- UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
- UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
- UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
- UBS AM opened 60 new positions and closed 124 in Q1 2022.
- UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.